AR019198A1 - Sistema implantable para la administracion subcutanea o local de un adrogeno e implante. - Google Patents

Sistema implantable para la administracion subcutanea o local de un adrogeno e implante.

Info

Publication number
AR019198A1
AR019198A1 ARP990103194A ARP990103194A AR019198A1 AR 019198 A1 AR019198 A1 AR 019198A1 AR P990103194 A ARP990103194 A AR P990103194A AR P990103194 A ARP990103194 A AR P990103194A AR 019198 A1 AR019198 A1 AR 019198A1
Authority
AR
Argentina
Prior art keywords
subcutaneous
local administration
implant
implantable system
adrogen
Prior art date
Application number
ARP990103194A
Other languages
English (en)
Original Assignee
Population Council Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Population Council Inc filed Critical Population Council Inc
Publication of AR019198A1 publication Critical patent/AR019198A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Esta invencion se refiere a un sistema implantable para su uso como contracepcion masculina y como tratamiento de hipertrofia prostáticabenigna y otras afecciones. El sistema de implante incluye un imlante pretendido para una administracion por vía subcutánea o local que posee un nucleoque comprende un elastomero de siliconas y una matriz de droga recubierto por una membrana o recubrimiento de etil vinil acetato.
ARP990103194A 1998-07-02 1999-06-30 Sistema implantable para la administracion subcutanea o local de un adrogeno e implante. AR019198A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/109,760 US6117441A (en) 1998-07-02 1998-07-02 Silicone core long term androgen delivery implant

Publications (1)

Publication Number Publication Date
AR019198A1 true AR019198A1 (es) 2001-12-26

Family

ID=22329420

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990103194A AR019198A1 (es) 1998-07-02 1999-06-30 Sistema implantable para la administracion subcutanea o local de un adrogeno e implante.

Country Status (12)

Country Link
US (1) US6117441A (es)
EP (1) EP0970704B1 (es)
JP (1) JP4713700B2 (es)
AR (1) AR019198A1 (es)
AT (1) ATE223733T1 (es)
BR (1) BR9902528A (es)
CA (1) CA2276587C (es)
DE (1) DE69902852T2 (es)
DK (1) DK0970704T3 (es)
ES (1) ES2186280T3 (es)
HU (1) HU223690B1 (es)
PT (1) PT970704E (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006506385A (ja) * 2002-10-22 2006-02-23 ザ バイオメリックス コーポレーション 治療剤を小嚢内デリバリーするための方法およびシステム
CA2525792C (en) 2003-05-15 2015-10-13 Biomerix Corporation Reticulated elastomeric matrices, their manufacture and use in implantable devices
US20050131383A1 (en) * 2003-12-16 2005-06-16 How-Lun Chen Method for implanting flexible injection port
US20050131325A1 (en) * 2003-12-16 2005-06-16 How-Lun Chen Flexible injection port
US7763077B2 (en) 2003-12-24 2010-07-27 Biomerix Corporation Repair of spinal annular defects and annulo-nucleoplasty regeneration
EP3470108A1 (en) 2004-07-02 2019-04-17 Mati Therapeutics Inc. Treatment medium delivery device for delivery of treatment media to the eye
PT1781264E (pt) 2004-08-04 2013-10-16 Evonik Corp Métodos para o fabrico de dispositivis de administração e dispositivos para a mesma
WO2006026844A1 (en) * 2004-09-09 2006-03-16 Biolab Sanus Farmacêutica Ltda. Hormone delayed release composition on the basis of polyorganosiloxanes or ethylene vinyl acetate resp. process for its manufacture
US20060093639A1 (en) * 2004-10-29 2006-05-04 Starkebaum Warren L Method and device for destroying body tissue
GB0504657D0 (en) * 2005-03-05 2005-04-13 Psimedica Ltd Compositions and methods of treatment
CN103393483B (zh) 2006-03-31 2016-08-24 玛提治疗有限公司 用于鼻泪系统的药物释放方法、结构及组合物
US20090104243A1 (en) 2007-09-07 2009-04-23 Qlt Plug Delivery, Inc. - Qpdi Drug cores for sustained release of therapeutic agents
CN101861135A (zh) 2007-09-07 2010-10-13 Qlt栓塞输送公司 泪道植入物检测
US8728528B2 (en) 2007-12-20 2014-05-20 Evonik Corporation Process for preparing microparticles having a low residual solvent volume
JP5869551B2 (ja) * 2010-03-16 2016-02-24 タイタン ファーマシューティカルズ インコーポレイテッド 薬物送達のための不均一な埋め込み型デバイス
EP2476409A1 (en) 2011-01-14 2012-07-18 Université Catholique De Louvain Implant comprising a core and a tube encasing the core
CN106573133B (zh) 2014-08-19 2020-03-03 加利福尼亚大学董事会 用于局部药物递送的植入物及其使用方法
AU2019275409B2 (en) 2018-05-24 2024-08-15 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
CN111971026A (zh) 2018-05-24 2020-11-20 塞拉尼斯伊娃高性能聚合物公司 用于持续释放大分子药物化合物的可植入器件
US11689849B2 (en) 2018-05-24 2023-06-27 Nureva, Inc. Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones
US11173291B2 (en) 2020-03-20 2021-11-16 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
US11338119B2 (en) 2020-03-20 2022-05-24 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery
US11344526B2 (en) 2020-03-20 2022-05-31 The Regents Of The University Of California Implantable drug delivery devices for localized drug delivery

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3832252A (en) * 1970-09-29 1974-08-27 T Higuchi Method of making a drug-delivery device
US3710795A (en) * 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
US4052505A (en) * 1975-05-30 1977-10-04 Alza Corporation Ocular therapeutic system manufactured from copolymer
US4191741A (en) * 1978-09-22 1980-03-04 Eli Lilly And Company Removable drug implant
US4234571A (en) * 1979-06-11 1980-11-18 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide derivatives of luteinizing hormone releasing hormone
US4451253A (en) * 1980-12-18 1984-05-29 Harman Sherman M Means and method for administering medicinals
JPS62174031A (ja) * 1985-10-11 1987-07-30 Sumitomo Pharmaceut Co Ltd 高分子量薬物含有徐放性製剤
US4666441A (en) * 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches
US5028430A (en) * 1987-05-08 1991-07-02 Syntex (U.S.A.) Inc. Delivery systems for the controlled administration of LHRH analogs
DE19975054I2 (de) * 1987-08-08 2000-04-13 Akzo Nobel Nv Kontrazeptives Implantat
US5035891A (en) * 1987-10-05 1991-07-30 Syntex (U.S.A.) Inc. Controlled release subcutaneous implant
GB8806367D0 (en) * 1988-03-17 1988-04-13 Erba Carlo Spa Siloxane matrices with internal non-uniform drug distribution
US4942037A (en) * 1988-06-02 1990-07-17 Merck & Co., Inc. Transdermal delivery systems
IN171596B (es) * 1989-06-27 1992-11-21 Cohen Michael
AU651654B2 (en) * 1992-01-14 1994-07-28 Endo Pharmaceuticals Solutions Inc. Manufacture of water-swellable hydrophilic articles and drug delivery devices
US5266325A (en) * 1990-09-28 1993-11-30 Hydro Med Science Division Of National Patent Development Corp. Preparation of homogeneous hydrogel copolymers
JPH05238929A (ja) * 1992-02-27 1993-09-17 Sumitomo Pharmaceut Co Ltd 代謝性骨疾患治療用長期持続性製剤
FR2695826B1 (fr) * 1992-09-21 1995-01-06 Theramex Nouvelles compositions pharmaceutiques à base de dérivés de nomégestrol et leurs procédés d'obtention.
US5660848A (en) * 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
US5733565A (en) * 1996-02-23 1998-03-31 The Population Council, Center For Biomedical Research Male contraceptive implant

Also Published As

Publication number Publication date
CA2276587C (en) 2006-10-24
HU223690B1 (hu) 2004-12-28
PT970704E (pt) 2003-01-31
HUP9902225A2 (hu) 2002-01-28
ES2186280T3 (es) 2003-05-01
DK0970704T3 (da) 2003-01-20
US6117441A (en) 2000-09-12
ATE223733T1 (de) 2002-09-15
DE69902852D1 (de) 2002-10-17
BR9902528A (pt) 2000-05-02
CA2276587A1 (en) 2000-01-02
JP2000044489A (ja) 2000-02-15
DE69902852T2 (de) 2003-01-16
EP0970704A1 (en) 2000-01-12
JP4713700B2 (ja) 2011-06-29
EP0970704B1 (en) 2002-09-11
HU9902225D0 (en) 1999-08-30

Similar Documents

Publication Publication Date Title
AR019198A1 (es) Sistema implantable para la administracion subcutanea o local de un adrogeno e implante.
DE60303705D1 (de) Beschichteter Stent für die Freisetzung aktiver Substanzen
ATE346567T1 (de) Stent mit sicherheitsballonkatheter
DE60330144D1 (de) Beschichtung von stents mit verzögerter wirkstofffreisetzung
ES2184895T3 (es) Sistema no polimerico de administracion con liberacion retardada.
WO2001008717A9 (en) Controlled release implantable devices
BR0203650A (pt) Estentor de auto-articulação
PT794790E (pt) Libertacao localizada de factores que aumentam a sobrevivencia de celulas transplantadas
ES2050070B1 (es) Procedimiento para la preparacion de una composicion destinada a la liberacion prolongada y controlada de una substancia peptidica.
GB2352180B (en) Fragrance emitting device
ATE509641T1 (de) Beschichtung für implantierbare vorrichtungen und verfahren zu ihrer herstellung
WO1995028124A3 (en) An adjunctive polymer system for use with medical device
WO2005074547A3 (en) Inflatable porous implants and methods for drug delivery
ATE431165T1 (de) Bioaktive beschichtungen zur vermeidung von gewebewachstum auf künstlichen herzklappen
ATE461717T1 (de) Intraluminale vorrichtung mit einer therapeutisches-mittel enthaltenden beschichtung
MY113488A (en) Compounds with growth hormone releasing properties
ATE344083T1 (de) Einführvorrichtung mit doppelhülle für selbstexpandierbaren stent
BR9808703A (pt) Composição que fornece medicamento solúvel emágua de dissolução relativamente lenta e usosublingual
AU2003243232A1 (en) Sutureless retention device
WO2003082188A3 (en) Methods and drug delivery systems for the treatment of orofacial diseases
DE60225178D1 (de) Auf in vivo abbaubaren und quellbaren modifizierten dextranhydrogelen basierende systeme zur stosswe
PT1003477E (pt) Sistema terapeutico transdermico (tts), contendo polimeros de (met)acrilato com grupos amonio para administracao de levonorgestrel
NO970361D0 (no) Spraybart filmdannende system som frigjör aktive stoffer for anvendelse på planter
ES2169223T3 (es) Substancia anticancerosa que inhibe la metastasis cancerosa.
ATE515258T1 (de) Mukosales verabreichungssytem

Legal Events

Date Code Title Description
FB Suspension of granting procedure